| Michele D Solarte, MD | |
|
419 N Harrison St Ste 104, Princeton, NJ 08540-3521 | |
| (609) 921-9437 | |
| (609) 921-0277 |
| Full Name | Michele D Solarte |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 8 Years |
| Location | 419 N Harrison St Ste 104, Princeton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649626318 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 25MA10853200 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Princeton Eye Group, Pa | 8426027731 | 14 |
| Wills Eye Ophthalmology Clinic, Inc | 9133025166 | 129 |
News Archive
People who inject drugs and who are female, homeless or amphetamine users often share needles and syringes, and consequently run a higher risk of infection hepatitis C virus infection that affect the liver.
In celebration of World Heart Day on September 29, 2016, Royal Philips, a leading health technology company, today announced a new partnership with the World Heart Federation to help people better manage their heart health.
The Gerontological Society of America has been awarded a $5 million grant from the John A. Hartford Foundation to launch and develop the Hartford Change AGEnts Initiative, a multi-year project designed to create change in the practice environment that will improve the health of older adults, their families, and communities.
Researchers at the University of California, Santa Cruz, have developed a novel optical glucose sensor that could be used to provide continuous monitoring of glucose levels in diabetics and hospitalized patients. Recently published studies showed that the sensor detects glucose under physiological conditions, giving a reversible fluorescent signal that changes intensity in response to changes in the concentration of glucose.
Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern Medical Center are trying to understand how Fen-phen behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.
› Verified 1 days ago
| Entity Name | Princeton Eye Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164528980 PECOS PAC ID: 8426027731 Enrollment ID: O20041001000817 |
News Archive
People who inject drugs and who are female, homeless or amphetamine users often share needles and syringes, and consequently run a higher risk of infection hepatitis C virus infection that affect the liver.
In celebration of World Heart Day on September 29, 2016, Royal Philips, a leading health technology company, today announced a new partnership with the World Heart Federation to help people better manage their heart health.
The Gerontological Society of America has been awarded a $5 million grant from the John A. Hartford Foundation to launch and develop the Hartford Change AGEnts Initiative, a multi-year project designed to create change in the practice environment that will improve the health of older adults, their families, and communities.
Researchers at the University of California, Santa Cruz, have developed a novel optical glucose sensor that could be used to provide continuous monitoring of glucose levels in diabetics and hospitalized patients. Recently published studies showed that the sensor detects glucose under physiological conditions, giving a reversible fluorescent signal that changes intensity in response to changes in the concentration of glucose.
Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern Medical Center are trying to understand how Fen-phen behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.
› Verified 1 days ago
| Entity Name | Princeton Eye Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1801961313 PECOS PAC ID: 8426027731 Enrollment ID: O20050407000922 |
News Archive
People who inject drugs and who are female, homeless or amphetamine users often share needles and syringes, and consequently run a higher risk of infection hepatitis C virus infection that affect the liver.
In celebration of World Heart Day on September 29, 2016, Royal Philips, a leading health technology company, today announced a new partnership with the World Heart Federation to help people better manage their heart health.
The Gerontological Society of America has been awarded a $5 million grant from the John A. Hartford Foundation to launch and develop the Hartford Change AGEnts Initiative, a multi-year project designed to create change in the practice environment that will improve the health of older adults, their families, and communities.
Researchers at the University of California, Santa Cruz, have developed a novel optical glucose sensor that could be used to provide continuous monitoring of glucose levels in diabetics and hospitalized patients. Recently published studies showed that the sensor detects glucose under physiological conditions, giving a reversible fluorescent signal that changes intensity in response to changes in the concentration of glucose.
Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern Medical Center are trying to understand how Fen-phen behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michele D Solarte, MD 419 N Harrison St Ste 104, Princeton, NJ 08540-3521 Ph: (609) 921-9437 | Michele D Solarte, MD 419 N Harrison St Ste 104, Princeton, NJ 08540-3521 Ph: (609) 921-9437 |
News Archive
People who inject drugs and who are female, homeless or amphetamine users often share needles and syringes, and consequently run a higher risk of infection hepatitis C virus infection that affect the liver.
In celebration of World Heart Day on September 29, 2016, Royal Philips, a leading health technology company, today announced a new partnership with the World Heart Federation to help people better manage their heart health.
The Gerontological Society of America has been awarded a $5 million grant from the John A. Hartford Foundation to launch and develop the Hartford Change AGEnts Initiative, a multi-year project designed to create change in the practice environment that will improve the health of older adults, their families, and communities.
Researchers at the University of California, Santa Cruz, have developed a novel optical glucose sensor that could be used to provide continuous monitoring of glucose levels in diabetics and hospitalized patients. Recently published studies showed that the sensor detects glucose under physiological conditions, giving a reversible fluorescent signal that changes intensity in response to changes in the concentration of glucose.
Once hailed as a miracle weight-loss drug, Fen-phen was removed from the market more than a decade ago for inducing life-threatening side effects, including heart valve lesions. Scientists at UT Southwestern Medical Center are trying to understand how Fen-phen behaves in the brain in order to develop safer anti-obesity drugs with fewer side effects.
› Verified 1 days ago
Dr. Anita I Miedziak, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 North Harrison Street, Suite 104, Princeton, NJ 08540 Phone: 609-921-9437 Fax: 609-688-9941 | |
Dr. Stephen M Felton, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 North Harrison Street, Suite 104, Princeton, NJ 08540 Phone: 609-921-9437 Fax: 609-688-9941 | |
Dr. Richard D Reynolds, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 North Harrison Street, Suite 104, Princeton, NJ 08540 Phone: 609-921-9437 Fax: 609-688-9941 | |
Chirag V Patel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 601 Ewing St, Ste C 17, Princeton, NJ 08540 Phone: 609-800-2393 | |
Dr. Samuel M Liu, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 North Harrison Street, Suite 104, Princeton, NJ 08540 Phone: 609-921-9437 Fax: 609-688-9941 | |
Dr. Michael Y Wong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 North Harrison Street, Suite 104, Princeton, NJ 08540 Phone: 609-921-9437 Fax: 609-688-9941 | |
Peter Murr, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 419 N Harrison St Ste 104, Princeton, NJ 08540 Phone: 609-921-9437 |